Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DROXIA
- Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
- Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts
- Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere
- Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMT CTN 1507)
- Treatment of Hemoglobin SC Disease With Hydroxyurea
- Realizing Effectiveness Across Continents With Hydroxyurea (REACH)
- Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- Sickle Cell Disease - Stroke Prevention in Nigeria Trial
- Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
- Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea
- Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
- Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
Clinical trials list
click for details